DE68917049D1 - Furylthiazol-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten. - Google Patents

Furylthiazol-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.

Info

Publication number
DE68917049D1
DE68917049D1 DE68917049T DE68917049T DE68917049D1 DE 68917049 D1 DE68917049 D1 DE 68917049D1 DE 68917049 T DE68917049 T DE 68917049T DE 68917049 T DE68917049 T DE 68917049T DE 68917049 D1 DE68917049 D1 DE 68917049D1
Authority
DE
Germany
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
furylthiazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68917049T
Other languages
English (en)
Other versions
DE68917049T2 (de
Inventor
Hisashi Takasugi
Yousuke Katsura
Yoshikazu Inoue
Tetsuo Tomishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819365A external-priority patent/GB8819365D0/en
Priority claimed from GB898905818A external-priority patent/GB8905818D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE68917049D1 publication Critical patent/DE68917049D1/de
Application granted granted Critical
Publication of DE68917049T2 publication Critical patent/DE68917049T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE68917049T 1988-08-15 1989-08-11 Furylthiazol-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten. Expired - Fee Related DE68917049T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819365A GB8819365D0 (en) 1988-08-15 1988-08-15 New furylthiazole derivatives processes for preparation thereof & pharmaceutical composition comprising same
GB898905818A GB8905818D0 (en) 1989-03-14 1989-03-14 New furylthiazole derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

Publications (2)

Publication Number Publication Date
DE68917049D1 true DE68917049D1 (de) 1994-09-01
DE68917049T2 DE68917049T2 (de) 1995-01-05

Family

ID=26294284

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68917049T Expired - Fee Related DE68917049T2 (de) 1988-08-15 1989-08-11 Furylthiazol-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.

Country Status (12)

Country Link
EP (1) EP0355612B1 (de)
JP (1) JP2814594B2 (de)
KR (1) KR900003166A (de)
CN (1) CN1040796A (de)
AT (1) ATE109144T1 (de)
AU (1) AU3934689A (de)
DE (1) DE68917049T2 (de)
DK (1) DK391089A (de)
FI (1) FI893795A (de)
IL (1) IL91152A0 (de)
NO (1) NO893256L (de)
PT (1) PT91415B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
JPH06509353A (ja) * 1991-08-02 1994-10-20 藤沢薬品工業株式会社 フリルチアゾールおよびそのｈ２−受容体拮抗剤および抗菌剤としての用途
GB9211163D0 (en) * 1992-05-26 1992-07-08 Fujisawa Pharmaceutical Co New oxazole derivatives
GB9326611D0 (en) * 1993-12-31 1994-03-02 Fujisawa Pharmaceutical Co New compound
DE102004008141A1 (de) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
JPWO2016098793A1 (ja) * 2014-12-17 2017-09-28 塩野義製薬株式会社 環状グアニジル基を有するチアゾール誘導体
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2961923D1 (en) * 1978-01-18 1982-03-11 Ici Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
JPS5936674A (ja) * 1982-08-25 1984-02-28 Yamanouchi Pharmaceut Co Ltd Ｎ−置換グアニジノチアゾ−ル誘導体およびその製造法
JPS59225186A (ja) * 1983-05-18 1984-12-18 Yamanouchi Pharmaceut Co Ltd 新規なグアニジノチアゾ−ル誘導体及びその製造方法
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
JPS62273977A (ja) * 1986-05-21 1987-11-28 Yoshitomi Pharmaceut Ind Ltd フリルチアゾ−ル化合物
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents

Also Published As

Publication number Publication date
CN1040796A (zh) 1990-03-28
NO893256D0 (no) 1989-08-14
FI893795A (fi) 1990-02-16
DK391089D0 (da) 1989-08-09
IL91152A0 (en) 1990-03-19
EP0355612B1 (de) 1994-07-27
ATE109144T1 (de) 1994-08-15
FI893795A0 (fi) 1989-08-11
PT91415A (pt) 1990-03-08
EP0355612A2 (de) 1990-02-28
EP0355612A3 (en) 1990-08-22
AU3934689A (en) 1990-02-15
PT91415B (pt) 1995-05-04
KR900003166A (ko) 1990-03-23
JPH0272177A (ja) 1990-03-12
JP2814594B2 (ja) 1998-10-22
DK391089A (da) 1990-02-16
NO893256L (no) 1990-02-16
DE68917049T2 (de) 1995-01-05

Similar Documents

Publication Publication Date Title
ATA249588A (de) 4h-1-benzopyran-4-on-derivate oder deren salze, verfahren zur herstellung derselben und pharmazeutische zusammensetzung, welche dieselben als wirkstoff enthalten
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
ATE113585T1 (de) Aminsäure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE56021T1 (de) Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel.
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ZA904893B (en) Iibeta-aryl-4-estrenes,process for their production as well as their use as pharmaceutical agents
ATA95989A (de) Pyridoncarbonsäurederivate und salze hievon, verfahren zur herstellung derselben und antibakterielle mittel, welche diese enthalten
DE19975037I2 (de) 3H-Imidazo-5,1-d-1,2,3,5-tetrazin-4-on-Derivate Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
FR2638161B1 (fr) Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
ATA56790A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
DE68917049D1 (de) Furylthiazol-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
ATA95690A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA260590A (de) Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
EP0288758A3 (en) Dihydropyridinamides, process for their preparation and their use in medicines
DE3852332D1 (de) 4-Thiochinazolin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellungen.
ATA328587A (de) Neue furanuronsaeure-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE68903059D1 (de) Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.
ATA146488A (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATA67488A (de) Immunglobulinkonjugate, verfahren zu deren herstellung und anwendung sowie pharmazeutische mittel, die diese enthalten
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
HUT49590A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same as active ingredient

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee